|
[1]
|
叶雅雯, 王丽姿. 护士参与心房颤动患者抗凝管理模式的研究现状[J]. 中国实用护理杂志, 2017, 33(15): 1191-1195.
|
|
[2]
|
中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会, 中国房颤中心联盟心房颤动防治专家工作委员会. 心房颤动: 目前的认识和治疗建议(2021) [J]. 中华心律失常学杂志, 2022, 26(1): 15-88.
|
|
[3]
|
Hart, R.G., Pearce, L.A. and Aguilar, M.I. (2007) Meta-Analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation. Annals of Internal Medicine, 146, 857-867. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Steffel, J., Collins, R., Antz, M., et al. (2021) 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. EP Europace, 23, 1612-1676. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Hindricks, G., Potpara, T., Dagres, N., et al. (2021) 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration with the European Asso-ciation for Cardio-Thoracic Surgery (EACTS): The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed with the Special Contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal, 42, 373-498. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
吴楠, 顾晴, 关玉霞, 李宾宾. 心房颤动患者华法林抗凝治疗的管理现状[J]. 中华护理杂志, 2014, 49(3): 337-340.
|
|
[7]
|
王广宁. 基于计划行为理论的服用华法林房颤患者自我管理的影响因素分析[D]: [硕士学位论文]. 青岛: 青岛大学, 2020.
|
|
[8]
|
伍珊珊, 黄远平, 谢铄, 等. 非瓣膜病房颤患者口服新型抗凝药依从性的调查[J]. 中华护理杂志, 2019, 54(6): 878-882.
|
|
[9]
|
Fisher, J.D. and Fisher, W.A. (1992) Changing AIDS-Risk Behavior. Psychological Bulletin, 111, 455-474. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
谭琛. 《2020 ECS/EACTS心房颤动诊断和管理指南》解读[J]. 中国循证心血管医学杂志, 2021, 13(2): 129-132.
|
|
[11]
|
陈鸿雁. 统计学[M]. 北京: 北京理工大学出版社, 2021.
|
|
[12]
|
杜宜修, 吴芳琴, 卢晓英, 等. 多学科团队延续性护理模式在心房颤动患者中的应用研究[J]. 中华护理杂志, 2020, 55(7): 969-974.
|
|
[13]
|
司在霞, 郭灵霞, 周敏, 曹广庆. 修订版Morisky服药依从性量表用于抗凝治疗患者的信效度检测[J]. 护理学杂志, 2012, 27(22): 23-26.
|
|
[14]
|
Obamiro, K. and Lee, K. (2019) Information Over-load in Patients with Atrial Fibrillation: Can the Cancer Information Overload (CIO) Scale Be Used? Patient Education and Counseling, 102, 550-554. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
宋婷, 忻笑, 崔培荣, 李贤华. 抗凝药知识问卷在中国心房颤动患者中应用的信效度研究[J]. 中国实用护理杂志, 2021, 37(16): 1218-1222.
|
|
[16]
|
康洪彬, 李艳君. 中文版改良服药信念量表在临床中的应用价值探讨[J]. 中国卫生统计, 2021, 38(5): 766-768.
|
|
[17]
|
张诚霖, 杨小芳, 卢冰清, 等. 心房颤动患者生命质量量表的汉化及信效度检验[J]. 中国实用护理杂志, 2017, 33(19): 1441-1445.
|
|
[18]
|
黄从新, 张澍, 黄德嘉, 华伟. 心房颤动: 目前的认识和治疗的建议-2018[J]. 中国心脏起搏与心电生理杂志, 2018, 32(4): 315-368.
|
|
[19]
|
(2018) Corrigendum to: 2016 ESC Guidelines for the Management of Atrial Fibrillation Devel-oped in Collaboration with EACTS. European Heart Journal, 39, 1109. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Desteghe, L., Engelhard, L., Raymaekers, Z., et al. (2016) Knowledge Gaps in Patients with Atrial Fibrillation Revealed by a New Validated Knowledge Questionnaire. International Journal of Cardiology, 223, 906-914. [Google Scholar] [CrossRef] [PubMed]
|